Skip to content
← Full study record

NCT00859937 · MORE INFO

Limitations, agreements, and source contact

Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors · Source last updated 2018-04-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
swong@mcw.edu
organization
University of Chicago Comprehensive Cancer Center
phone
773-702-9311
title
Dr. Stuart Wong
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
swong@mcw.edu
organization
University of Chicago Comprehensive Cancer Center
phone
773-702-9311
title
Dr. Stuart Wong

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice